Additionally, pre-trauma baseline differences in endocannabinoid signaling could predispose specific individuals to be more vulnerable to developing PTSD and to develop certain symptoms [55] or to rely on emotional numbing as a coping mechanism, possibly making it more consistently linked to CB1R levels over time. This evidence concerns the gene CNR1 and post-traumatic stress disorder.